A breakthrough in treating an aggressive form of prostate cancer could boost survival rates, according to new research.
About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality ...
The trial was conducted in 17 clinical centres, in partnership with the Society of Urologic Oncology Clinical Trials Consortium.
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...